收藏切换
Research progress on clinical application of targeting proprotein convertase subtilisin/kexin type 9 inhibitors
收藏切换
Yali GAO1, Nianxi YU2, Xingyun HOU2, Xia TAO2, *
World Clinical Drug | 2022, 43(6) : 651 - 662
Less
收藏切换
World Clinical Drug | 2022, 43(6): 651-662
• Topic •
Research progress on clinical application of targeting proprotein convertase subtilisin/kexin type 9 inhibitors
Full
Yali GAO1, Nianxi YU2, Xingyun HOU2, Xia TAO2, *
Affiliations
  • 1.Department of Pharmacy, 2nd Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian Province, China
  • 2.Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China
Published: 2022-06-10 doi: 10.13683/j.wph.2022.06.002
Outline
收藏切换

Dyslipidemia, characterized by elevated low density lipoprotein-cholesterol (LDL-C), is an important risk factor for atherosclerotic cardiovascular disease (ASCVD). Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a class of compounds that inhibit PCSK9 and are a class of new lipid-lowering drugs. It interferes with the recycling of low density lipoprotein receptor (LDLR), thus hindering LDL-C clearance mediated by LDLR, which brings new hope for lipid-lowering therapy. This article reviewed the discovery, structure, regulation and biological functions of PCSK9 targets, focusing on the pharmacodynamics, pharmacokinetics and recent clinical research progress of monoclonal antibodies and small interfering RNA drugs, in order to provide reference for clinical diagnosis and treatment.

proprotein convertase subtilisin/kexin type 9  /  low density lipoprotein-cholesterol  /  atherosclerotic cardiovascular disease  /  monoclonal antibody  /  small interfering RNA
高雅莉, 余年喜, 侯幸赟, 陶霞. 靶向前蛋白转化酶枯草溶菌素9抑制剂临床应用研究进展. 世界临床药物, 2022 , 43 (6) : 651 -662 . DOI: 10.13683/j.wph.2022.06.002
Yali GAO, Nianxi YU, Xingyun HOU, Xia TAO. Research progress on clinical application of targeting proprotein convertase subtilisin/kexin type 9 inhibitors[J]. World Clinical Drug, 2022 , 43 (6) : 651 -662 . DOI: 10.13683/j.wph.2022.06.002
Year 2022 volume 43 Issue 6
11
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.06.002
  • Receive Date:2021-12-01
  • Online Date:2026-11-19
  • Published:2022-06-10
Article Data
Affiliations
History
  • Received:2021-12-01
  • Revised:2022-04-12
Funding
Affiliations
    1.Department of Pharmacy, 2nd Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian Province, China
    2.Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200433, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.06.002
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT